🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The new P2Y12 inhibitors prasugrel (Efient®-Effient®) and ticagrelor (Brili...
Status
Completed
Location
Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière
Start Date
2017-01-09
Trial ID
NCT02617290
Treatments Being Tested
This phase 2B study is a multi-center, randomized, double-blind, placebo-co...
Status
Completed
Location
Woodland Research Northwest, LLC
Start Date
2019-09-24
Trial ID
NCT04122170
This is a Phase 1, first-in-human, randomized, double-blind, placebo-contro...
Status
Completed
Location
PPD
Start Date
2018-04-03
Trial ID
NCT03492385
This is a Phase 2A, randomized, double-blind, placebo-controlled, single do...
Status
Completed
Location
PPD
Start Date
2019-04-16
Trial ID
NCT03928353
A phase I, open-label study comparing the pharmacokinetics, pharmacodynamic...
Status
Completed
Location
Research Site
Start Date
2013-12-29
Trial ID
NCT02022748
Treatments Being Tested
This study is designed to test the hypothesis that the onset of the antipla...
Status
Unknown
Location
Fuwai hospital
Start Date
2015-06
Trial ID
NCT02513004
Treatments Being Tested
Multicenter, international, randomized, placebo-controlled, double-blind tr...
Status
Completed
Location
University Hospital Kralovske Vinohrady
Start Date
2018-08-01
Trial ID
NCT03551964
Treatments Being Tested
This is a Phase 1, randomized, double-blind, placebo-controlled, single asc...
Status
Terminated
Location
Beijing Friendship Hospital
Start Date
2021-12-25
Trial ID
NCT05162131
Treatments Being Tested